FIELD: medicine.
SUBSTANCE: invention relates to medicine and can be used to predict the long-term effectiveness of treatment of patients with drug-resistant form of arterial hypertension. The method for predicting the long-term antihypertensive efficacy of the renal denervation procedure in patients with resistant arterial hypertension is carried out as follows: a patient in a hospital is measured β-adrenoreactivity of erythrocyte membranes of peripheral blood before and 7 days after the procedure, and with a decrease in the value of β-adrenergic reactivity by 30% and more relative to the original predict a steady decrease in blood pressure by 10 mm Hg. and more after 2 years after the intervention.
EFFECT: use of the invention makes it possible to predict a stable decrease in blood pressure (BD) 2 years after PP, which makes it possible to identify patients with insufficient long-term effectiveness of intervention, who require more careful observation and an earlier change in treatment tactics in order to reduce the risk of possible cardiovascular complications.
1 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF SELECTION OF PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION FOR CONDUCTING THE PROCEDURE OF SYMPATHETIC DENERVATION OF RENAL ARTERIES | 2017 |
|
RU2658476C1 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF THE PROCEDURE OF SYMPATHETIC RENAL DENERVATION OF RENAL ARTERIES IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION COMBINED WITH TYPE 2 DIABETES MELLITUS | 2021 |
|
RU2772544C1 |
| METHOD FOR SELECTING PATIENTS SUFFERING FROM DRUG-RESISTANT ARTERIAL HYPERTENSION FOR PERFORMING RENAL SYMPATHETIC DENERVATION | 2014 |
|
RU2563449C1 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF NEPHROPROTECTION IN SELECTING THE PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION ASSOCIATED WITH TYPE 2 DIABETES MELLITUS FOR THE SYMPATHETIC RENAL DENERVATION OF RENAL ARTERIES | 2019 |
|
RU2728093C1 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF THE RENAL DENERVATION PROCEDURE FOR THE SELECTION OF PATIENTS WITH ARTERIAL HYPERTENSION RESISTANT TO DRUG THERAPY IN ITS IMPLEMENTATION | 2020 |
|
RU2750023C1 |
| METHOD FOR PREDICTING IMPROVEMENT OF RENAL HEMODYNAMICS 6 MONTHS AFTER PROCEDURE OF SYMPATHETIC DENERVATION OF RENAL ARTERIES IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION COMBINED WITH TYPE 2 DIABETES MELLITUS | 2023 |
|
RU2807270C1 |
| METHOD OF EVALUATING EFFECTIVENESS OF RADIOFREQUENCY SYMPATHETIC DENERVATION OF RENAL ARTERIES IN PATIENTS SUFFERING DRUG-RESISTANT ARTERIAL HYPERTENSION | 2015 |
|
RU2578461C1 |
| METHOD FOR PREDICTION OF IMPROVEMENT OF LEFT VENTRICULAR DIASTOLIC FUNCTION IN 6 MONTHS AFTER PROCEDURE OF SYMPATHETIC DENERVATION OF RENAL ARTERIES IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION COMBINED WITH TYPE 2 DIABETES MELLITUS | 2023 |
|
RU2817191C1 |
| METHOD OF SELECTING PATIENTS WITH RESISTANT HYPERTENSION YOUNGER THAN 60 YEARS WITH DISTURBED CEREBRAL BLOOD FLOW RESERVE FOR SAFE AND EFFECTIVE TREATMENT BY RENAL DENERVATION | 2018 |
|
RU2687009C1 |
| METHOD FOR PREDICTION OF ENDOTHELIAL FUNCTION CONDITION IN ANTIHYPERTENSIVE THERAPY | 2009 |
|
RU2406436C1 |
